No Significant Reduction of Circulating Endothelial-Derived and Platelet-Derived Microparticles in Patients with Psoriasis Successfully Treated with Anti-IL12/23

Figure 3

IL12/23 blockage did not decrease the level of circulating CD41a and CD31 MPs in patients with severe psoriasis despite clinical improvement.